Mankind Pharma IPO Review & Recommendations

Apply for Listing Gain at Cut-off Price

60 to 70 % maal bech ke apply karo...
mandi ki asha 75% teji ki asha 25% he...
4300 cr. + full ofs + 35% retail + 1080 rs. value ... ye sab kuch kaam ka nahi , jo bhi kaam ka he wo papi ka maths he jisme ye kuch set nahi hota.. to becho aur aram karo..

1

Apply for Long Term at Cut-off Price

This is a portfolio stock. Any one who can buy this kind of company for long time will have positive surprise in coming periods. I think applying minimum lot for long term is very good for health of our portfolio.

Avoid

THe issue is such a huge OFS. Nothing foes to the company. Also price band is very high. Nothing left on the table for investors. Pure OFS of this size implies company gets nothing from IPO.

Avoid this Ipo at any cost and teach lesson to greedy promoters. Let them buy their own IPO to save face.

4

Avoid

Low profit at time of listing according GMP.

1

Neutral

High Price
No listing gain difrence

2

Avoid

Very high premium

1

Avoid

Highly priced

3

Avoid

SELLER 65 NEAR MANKIND. NOTHING WILL HAPPAND IN THIS IPO

Apply for Long Term at Upper Price Band

Strong growth outlook with almost 50% + market share in its core products
15% listing gain possible but try for long term
Lamba sochke agar listing me ban jaye to aur acchha hoga

1

Avoid

Hugely overpriced. Avoid like Corona

1

Apply for Long Term at Upper Price Band

There us good y-o-y growth of both revenue and profit so Subscribe at upperband

1

Neutral

Wait for post-listing correction to accumulate for long term.

1

Apply for Long Term at Upper Price Band

It will be a blockbuster ipo .Forward pe will be less than 25 which is less compared to its peers .

Avoid

EXISTING INVESTORS IN MANKIND PHARMA GET RICH
HIGH VALUATION
LITERALLY AN ATTEMPT TO PROP UP THE COMPANY VALUE BY OUTSIDE MONEY

2

Neutral

Nothing much left on the table.
Big size IPO.
New HNI rules.
Recent listings are not giving profit.
GMP below 10%

4

Avoid

Very Expensive IPO with FV of 1 INR.
Avoid such IPOs which have FV of less then 5 INR.

1

Apply for Short Term at Upper Price Band

Applay

1

Apply for Listing Gain at Cut-off Price

Go long only company is surprise you with March result. So don't go with market negativity.
As per me it is 100% long and if want to sell then 55 is range to keep in mind.

1

Avoid

The issue is too pricey. There is nothing left for the investors on the table. Company fundamentals are good so, we can purchase from the secondary market at a cheaper price after listing.

1

Avoid

Overpriced

1

Avoid

Very high borrowings

3

Neutral

Isse Kam PE mein Secondary Market mein Acchi Pharma companies Mil jayegi.
Jinka 56 inches ka kaleja hai wo hi........

3

Apply for Long Term at Cut-off Price

This company is completely focussed on domestic market which will give consistent growth. If it can maintain its past CAGR, it will give very good profit in long term.

1

Apply for Long Term at Cut-off Price

one of the top and old pharma company....
hopefully it should not disappoint investor :)

Avoid

It is a big size IPO where the only purpose is to give exit to existing investor at big profit. So caution is warranted in applying in it. Many good pharma companies have fallen sharply and are better to buy. Dont go by gmp as seen in may past ipo it will vanish when issue closes

2